These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346. Zarrinmayeh H; Tromiczak E; Zimmerman DM; Rankl N; Ho KH; Dominguez E; Castaño A; Escribano A; Fernandez C; Jimenez A; Hornback WJ; Nisenbaum ES Bioorg Med Chem Lett; 2006 Oct; 16(19):5203-6. PubMed ID: 16872827 [TBL] [Abstract][Full Text] [Related]
25. Polarized sorting of AMPA receptors to the somatodendritic domain is regulated by adaptor protein AP-4. Matsuda S; Yuzaki M Neurosci Res; 2009 Sep; 65(1):1-5. PubMed ID: 19481121 [TBL] [Abstract][Full Text] [Related]
27. Recent progress in the development of allosteric modulators of mGluR5. Rodriguez AL; Williams R Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523 [TBL] [Abstract][Full Text] [Related]
28. Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity. Jiang J; Suppiramaniam V; Wooten MW Neurosignals; 2006-2007; 15(5):266-82. PubMed ID: 17622793 [TBL] [Abstract][Full Text] [Related]
29. AMPA Receptors as Therapeutic Targets for Neurological Disorders. Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691 [TBL] [Abstract][Full Text] [Related]
30. QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor. Macchiarulo A; De Luca L; Costantino G; Barreca ML; Gitto R; Pellicciari R; Chimirri A J Med Chem; 2004 Mar; 47(7):1860-3. PubMed ID: 15027880 [TBL] [Abstract][Full Text] [Related]
31. Positive modulators of AMPA receptors as a potential treatment for schizophrenia. Danysz W Curr Opin Investig Drugs; 2002 Jul; 3(7):1062-6. PubMed ID: 12186268 [TBL] [Abstract][Full Text] [Related]
32. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534 [TBL] [Abstract][Full Text] [Related]
33. 2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects. Szénási G; Vegh M; Szabo G; Kertesz S; Kapus G; Albert M; Greff Z; Ling I; Barkoczy J; Simig G; Spedding M; Harsing LG Neurochem Int; 2008 Jan; 52(1-2):166-83. PubMed ID: 17707550 [TBL] [Abstract][Full Text] [Related]
34. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala. Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096 [TBL] [Abstract][Full Text] [Related]
35. A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies. Jamieson C; Basten S; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Moir EM; Morrow JA; Papakosta M; Rankovic Z; Smith L Bioorg Med Chem Lett; 2010 Oct; 20(19):5753-6. PubMed ID: 20805031 [TBL] [Abstract][Full Text] [Related]